Results 121 to 130 of about 4,552 (200)

Integrating 3D Chromatography With Orbitrap Mass Spectrometry to Profile the Chemical Constituents in JTTZ Formula and Investigate Plasma Pharmacokinetic Changes in Obese Rats. [PDF]

Phytochem Anal
Zhou L, Hou N, Hou T, Li Z, Zhang Z, Tong X, Su H, Li X.   +7 more
europepmc   +1 more source

Cryptotanshinone differentially induces cell death in <i>ATP6V0D1</i>-deficient pancreatic cancer cells. [PDF]

Cancer Drug Resist
Chen F, Lin J, Cai X, Tang H, Li S, Liang R, Kang R, Zhang Z, Tang D, Liu J.   +9 more
europepmc   +1 more source

Multiscale analysis and optimal glioma therapeutic candidate discovery using the CANDO platform. [PDF]

J Cheminform
Xu S, Hu Y, Mangione W, Van Norden M, Elefteriou K, Falls Z, Samudrala R.   +6 more
europepmc   +1 more source

Design, Synthesis, and Evaluation of Novel Cryptotanshinone Derivatives for Activity against Triple-Negative Breast Cancer

Pharmaceutical Fronts
Siyu Liu, Panpan Zhang, Qingyan Sun
doaj   +1 more source

Clarifying the active ingredients & pharmacological mechanisms of traditional Chinese medicines via modern pharmaceutical analysis techniques. [PDF]

J Pharm Anal
Zhou H, Yang F, Bai H, Lv Y, Wang C, Liu R, Yu H, Han S, Li Z.   +8 more
europepmc   +1 more source

Tanshinone I, tanshinone IIA, and cryptotanshinone: key bioactive components modulating vascular smooth muscle cell function. [PDF]

Front Pharmacol
Li J, Wang W, Huang H, Zhou R, Yang Z, Cui Z, Niu Z, Shi S, Wang P.   +8 more
europepmc   +1 more source

Comprehensive bioinformatics and in vitro studies reveal the carcinogenic role and molecular basis of endocrine disruptors in prostate cancer. [PDF]

Front Cell Dev Biol
Yu F, Che B, Li W.
europepmc   +1 more source

Natural compounds targeting glycolysis and TME in ovarian cancer: from metabolic crosstalk to therapeutic potential. [PDF]

Front Pharmacol
Lv H, Jiang X, Zhang W, Kan S, Zhang Y, Wang B, Peng F, Yu C.   +7 more
europepmc   +1 more source

Targeting lung cancer with tanshinones: Current mechanistic evidence and emerging opportunities (Review). [PDF]

Oncol Rep
Guo Z, Li X, Suo P, Lin Z, Liu R, Chi C.
europepmc   +1 more source

Design and Synthesis of Cryptotanshinone Derivatives with Enhanced Anti-Triple-Negative Breast Cancer Activity via Ferroptosis Induction

Pharmaceutical Fronts
Qingyi Shi, Jingwen Guo, Qingyan Sun
doaj   +1 more source